DuPont Granted GRAS Status For Probiotic Range

MADISON, Wis.DuPont Nutrition & Health has been granted GRAS status for probiotic strains in its Bifidobacterium lactis range for use in all food products and dietary supplements. The U.S. Food and Drug Administration (FDA) previously granted the Bifidobacterium lactic strains full GRAS status for use in dairy applications.

With this new notification, FDA extends the GRAS status to food categories, such as juice, dry beverages, confectionery and bakery products and the dietary supplement market, where probiotics are widely used. DuPont previously had self-affirmed GRAS status for the use of its Bifidobacterium lactis strains in this range of additional applications.

Strains in the B. lactis range include Bifidobacterium lactis HN019, marketed as HOWARU® Bifido. Effective, stable and one of the most clinically studied probiotic strains available, these health-enhancing bacteria swiftly and simply raise the nutritional profile of food brands. Bifidobacterium lactis Bi-07 and Bifidobacterium lactis Bl-04 are part of the FloraFIT® custom probiotics range.

Along with proving the health benefits of the strains in our Bifidobacterium lactis range, we are committed to safety," said Scott Bush, vice president of marketing, DuPont Nutrition & Health. GRAS affirmation by FDA confirms that the science behind these strains is sufficient to guarantee their safety in foods and supplements. This greatly expands the application options available to our customers," he added.